Form 8-K - Current report:
SEC Accession No. 0001493152-25-017446
Filing Date
2025-10-08
Accepted
2025-10-08 17:10:43
Documents
21
Period of Report
2025-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 58615
2 EX-4.1 ex4-1.htm EX-4.1 86925
3 EX-5.1 ex5-1.htm EX-5.1 18954
4 EX-10.1 ex10-1.htm EX-10.1 51949
5 EX-10.2 ex10-2.htm EX-10.2 74051
6 EX-99.1 ex99-1.htm EX-99.1 16910
7 GRAPHIC ex5-1_001.jpg GRAPHIC 25376
8 GRAPHIC ex5-1_002.jpg GRAPHIC 19240
9 GRAPHIC ex5-1_003.jpg GRAPHIC 36207
10 GRAPHIC ex99-1_001.jpg GRAPHIC 6359
  Complete submission text file 0001493152-25-017446.txt   648924

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE brtx-20251006.xsd EX-101.SCH 3068
12 XBRL LABEL FILE brtx-20251006_lab.xml EX-101.LAB 34239
13 XBRL PRESENTATION FILE brtx-20251006_pre.xml EX-101.PRE 22394
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3567
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 251383077
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)